There is a cancer cure DCA... have you heard about it?
Flowers
2012/08/07 04:07:20
|
|
|||||
|
5 votes
|
|
63% | |||
|
2 votes
|
|
25% | |||
|
1 vote
|
|
13% | |||
Don't we deserve to know about this? to have the OPTION?
This is a very complex question but one very important thing to remember is in American drug research and manufacture is driven by profit. Pfizer, Johnson & Johnson, Eli Lily, and all the rest are first and foremost businesses. Not one of them would exist if there was no money to made.
Then you need to think about the FDA and their regulations and the potential for class action lawsuits if there is any problem with a drug.
Drug Patents are a big and complicated issue as is the relationship between Pharmaceutical companies and the medical profession.
There are far more people worrying about all that stuff than there are people worrying about the illness that drug could cure.
It typically takes about 5-10 years for a drug to go from the initial Phase 1 testing to FDA approval, so it would likely still be in trials in any case.
At this point, although there are a couple of very minor studies that indicate DCA may have some value in combating cancer, there is nothing even close to proven efficacy.
It's also worth noting that, contrary to the report you linked, DCA does have side effects. Including liver cancer and nerve toxicity. So it's not completely safe to take.
As far as big pharma and profits are concerned, this is partly true. It costs from about $200 million to $800 million to take a drug from phase 1 trials to FDA approval. One can hardly expect a business to invest that much money on a product that has little profit incentive. But there are other ways to fund research.
Additionally, even though big pharma may not be particularly interested in DCA itself, the theory behind it is not new, it's been around since the 1930's and there are other dru...
It typically takes about 5-10 years for a drug to go from the initial Phase 1 testing to FDA approval, so it would likely still be in trials in any case.
At this point, although there are a couple of very minor studies that indicate DCA may have some value in combating cancer, there is nothing even close to proven efficacy.
It's also worth noting that, contrary to the report you linked, DCA does have side effects. Including liver cancer and nerve toxicity. So it's not completely safe to take.
As far as big pharma and profits are concerned, this is partly true. It costs from about $200 million to $800 million to take a drug from phase 1 trials to FDA approval. One can hardly expect a business to invest that much money on a product that has little profit incentive. But there are other ways to fund research.
Additionally, even though big pharma may not be particularly interested in DCA itself, the theory behind it is not new, it's been around since the 1930's and there are other drugs already out there and being developed that use similar pathways towards curing cancer.
Here are some relevant links that tell the story quite a bit better:
http://www.nature.com/news/20...
http://abcnews.go.com/Health/...
http://www.cancer.org/AboutUs...
And here's the University of Alberta website regarding DCA:
http://www.dca.med.ualberta.c...